Sunday, August 1, 2021

Teva Pharmaceutical (TEVA) revised its financial forecast after low third-quarter sales

Teva Pharmaceutical (TEVA) announced its financial results on Thursday reporting low third-quarter sales and the company reduce its full-year revenue figures.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Teva reported 58 cents per share income for the quarter ended September 30, 2020, which is in line with the analyst’s estimates. The earing remains flat over the year. The company sales declined by 2.8% and the company earned $3.98 billion in sales, which is way behind than the $4.06 billion estimates. After the announcement, Teva stock floored 6.5% to 8.61.


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .

Sponsored


The sales of generic products climbed 2% to $928 million in North America, but generic product sales declined in Europe and international markets1% and 10% respectively year over year.

The revenue from the sales of Copaxone declined in all three geographies and it was declined most in the North America where it dipped to 13% to $236 million which is still $26 million higher than the analyst’s forecast.

But that beat forecasts by $26 million, SVB Leerink analyst Ami Fadia said in a note to clients. She retained her market perform rating on Teva stock.

Copaxone is facing tough competition due to generic copies but Teva said that Copaxone has ‘stabilized’ in the U.S.

Teva revised its sales figure for the year. Now Teva is looking to earn16.5 billion to $16.8 billion in sales, which is $150 million lower than previous guidance at the midpoint. Also, the earning per share has been revised and Teva expecting $2.40-$2.55 earnings per share whereas analysts’ estimates are $16.65 billion in sales and $2.48 per share.

Latest news

KLA Corporation (KLAC) announces new shipments of innovative device

Electronic manufacturing equipment manufacturer KLA Corporation (NASDAQ: KLAC) announced new shipments of its innovative device. It changes one of the major technological processes, and...

Novanta Inc. (NOVT) Acquires Schneider Electric Motion USA (SEM) For $115M Cash

Novanta Inc. (NASDAQ: NOVT) has acquired Schneider Electric Motion USA (SEM), a company that could contribute to its industrial automation development. Novanta Inc. (NOVT) purchased...

What Helped MannKind Corporation (MNKD) Stock Jump 11.6 Percent?

During the trading session on 28 June,2021 MannKind Corporation (NASDAQ: MNKD) advanced 11.60 percent to $5.31.This hike occurred as a result of recent efforts...

Identifying Value and Future Vision in Chewy Inc. (CHWY) Stock

Chewy Inc. (NYSE: CHWY), an online pet product retailer, recently introduced a new service, Connect With a Vet, featuring remote consultations with veterinarians. The...

Related news

KLA Corporation (KLAC) announces new shipments of innovative device

Electronic manufacturing equipment manufacturer KLA Corporation (NASDAQ: KLAC) announced new shipments of its innovative device. It changes one of the major technological processes, and...

Novanta Inc. (NOVT) Acquires Schneider Electric Motion USA (SEM) For $115M Cash

Novanta Inc. (NASDAQ: NOVT) has acquired Schneider Electric Motion USA (SEM), a company that could contribute to its industrial automation development. Novanta Inc. (NOVT) purchased...

What Helped MannKind Corporation (MNKD) Stock Jump 11.6 Percent?

During the trading session on 28 June,2021 MannKind Corporation (NASDAQ: MNKD) advanced 11.60 percent to $5.31.This hike occurred as a result of recent efforts...

Identifying Value and Future Vision in Chewy Inc. (CHWY) Stock

Chewy Inc. (NYSE: CHWY), an online pet product retailer, recently introduced a new service, Connect With a Vet, featuring remote consultations with veterinarians. The...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

1745

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam